Clinical Trial: Comparison Dual-Line Continuous Infusion Versus Single-Line Interruption for Norepinephrine in Maintaining Hemodynamic Stability in Critically Ill Patients (China)

Posted On: 2026-10-12

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparison Dual-Line Continuous Infusion Versus Single-Line Interruption for Norepinephrine in Maintaining Hemodynamic Stability in Critically Ill Patients'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133950

Registration Time: 2026/10/09

Type: Interventional study

Primary Sponsor: The 903rd Hospital of the Joint Logistic Support Force

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340726

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Comparison Dual-Line Continuous Infusion Versus Single-Line Interruption for Norepinephrine in Maintaining Hemodynamic Stability in Critically Ill Patients (China)